Michael Deininger Laboratory

The Deininger lab expertise is in the translational research of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecular targeted therapies.

Michael Deininger Laboratory at Versiti Blood Research Institute

 

Translational Research of Leukemia

The Deininger lab’s expertise focuses on translational research in leukemia, specifically the biology of myeloproliferative neoplasms and the development of molecular targeted therapies. We are especially interested in developing novel, anti-neoplastic targeted therapies in myeloid leukemia, as well as understanding the molecular mechanisms of cancer stem cell persistence and leukemia drug resistance.

Our lab orchestrates a multidisciplinary cancer research program, straddling genetics, biochemistry, molecular biology, pharmacology and biomedical engineering. We are proud of our vibrant team of scientists who strive to improve the diagnosis, deep analysis and therapeutics of myeloid leukemia.

 
Contact Us
Complete the contact us form to inquire about open lab positions or Dr. Deininger's research.
 
Publications
Read a select list of Dr. Deiningers publications.
 
Research
The Deininger lab’s expertise focuses on translational research of leukemia.
 
Team
Our laboratory includes research scientists, postdoctoral fellows, technicians, and undergraduate students. If you are interested in joining the team contact us.
 

Deininger Lab’s new article featured on the journal cover of Blood

We are excited that a recent paper, MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common B-chain cytokine receptor endocytosis, published by the Deininger Laboratory was featured on the cover of the February, 2022 article of Blood magazine.

Read the full article.

 
Join Versiti Blood Research Institute
Versiti Blood Research Institute, located in Milwaukee, Wisconsin, includes basic and clinical researchers in a variety of blood health fields.
 
Our Experts
Research investigators, postdoctoral fellows and laboratory staff at Versiti Blood Research Institute and Diagnostic Laboratories.
 
Versiti Blood Research Institute
Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.
 
Michael Deininger, MD, PhD
Dr. Deininger is the executive vice president and chief scientific officer at Versiti and the Mike and Cathy White Endowed Chair.